Pharmaceutical Business review

AcuNetx’s president and CEO resigns

Mr Waldorf’s position will be filled on an interim basis by Robert Corrigan, chairman of AcuNetx’s board and a seasoned executive with more than 25 years of experience in corporate finance and business development.

Mr Corrigan said: “I am enthusiastic and optimistic facing the challenge of building this company and am intent on growing sales, shoring up the balance sheet and strengthening our ties with the financial community.”